The Dr. Miguel Burnier 20/20 Campaign in support of the Ocular Pathology Laboratory

We don’t do research as an intellectual exercise. We do research because there is a patient at the end of the day.

 

Dr. Miguel N. Burnier, MD, PhD, FRCSC

Director, MUHC Ocular Pathology Lab

The Challenge

Nearly 500,000 Canadians are estimated to be living with a form of vision loss, which can have significant physical, emotional and financial impact on them and their families. With an aging population and the prevalence of vision loss in Canada expected to increase nearly 30 percent in the next decade, continued research in the field of ocular medicine is now becoming increasingly important in the hope of finding new treatments, and ultimately cures for these devastating illnesses.

The Solution

The MUHC’s Ocular Pathology Laboratory strives to translate basic research findings into treatment options for patients living with ocular disease. It is an international leader in research, education and consultation and the lab’s expertise is complimented with some of the most innovative research equipment and technology available.

The MUHC’s Ocular Pathology Laboratory is one of the largest laboratories in the world conducting ocular metastasis research, and Dr. Burnier and his team, along with MUHC ophthalmologists, pathologists, dermatologists, and oncologists, are working to find a cure for uveal melanoma, the most common type of ocular cancer that is mostly found in adults. Uveal melanoma has a very low survival rate and almost half of those who are diagnosed will succumb to the disease because it has the ability to spread rapidly to other organs, particularly the liver, where it is often diagnosed. The lab is working to change this outcome by developing more effective treatments while also investigating how these cancer cells spread, which may have an impact on a range of other ocular diseases.

Each and every day, Dr. Burnier’s Ocular Pathology Laboratory works to remain at the forefront of ocular diseases.  His leadership has helped the MUHC establish its position as an international centre and hub for clinical care and research related to eye disease.

To recognize Dr. Burnier’s outstanding achievements in this highly-specialized field, the MUHC Foundation has launched a $4 million campaign, which will include the creation of an endowment fund and support for the laboratory’s greatest needs. This essential investment will help the lab gain an even better understanding of the causes of eye disease while also facilitating potential early diagnoses for fatal ocular cancers such as uveal melanoma.

Your support of the Dr.Miguel Burnier 20/20 campaign will help:

  • Recruit the world’s top talent and provide them with specialized training to develop new treatments for ocular diseases
  • Establish an endowment fund to ensure a sustainable source of funding for continued innovation and leadership in the field of ocular disease
  • Expand the lab’s expertise to include cornea and lens speciality (cataracts)
  • Train the next generation of students on state-of-the-art equipment that is at the forefront of ocular care
  • Improve patient outcomes by providing a more efficient and non-invasive procedure that reflects clinical ophthalmology best practices
  • Create a visiting professorship that will specialize in OCT
  • Invest in a state-of-the-art lens database to facilitate research and optimization of intraocular lenses used in cataract surgery
  • Build a global network for training, research and clinical work in ocular diseases so that we can not only share but benefit from advances made in other countries and other populations
  • Facilitate early diagnosis and develop personalized treatments and therapies for patients living with ocular diseases

How you can help

For information on how you can support the Dr.Miguel Burnier 20/20 Campaign, please contact:

Miguel Burnier
Director of Development
miguel.burnierjr@muhc.mcgill.ca
514-934-1934, ext. 71205

Follow Us

LEAP has selected Centre universitaire de santé McGill - McGill University Health Centre cardiologist & Research Institute of the McGill University Health Centre researcher, Dr. Abhinav Sharma’s, MyHeart Counts Canada mobile application for their Healthy Future Accelerator. MyHeart Counts Canada’s goal is to get Canadians moving for improved cardiovascular health. Dr. Sharma’s app uses artificial-intelligence with real-time feedback and support to improve physical activity incrementally. LEAP is donating $100, 000 to support the continued development of Dr. Sharma’s app through the MUHC Foundation’s Fix Broken Hearts campaign. Watch: 📺 youtu.be/GG2HKWxVfxA

LEAP a choisi l'application mobile MyHeart Counts Canada du Dr Abhinav Sharma, cardiologue du CUSM et chercheur de l'IR-CUSM, pour leur accélérateur Horizons Santé. L’objectif de MyHeart Counts Canada est de faire bouger les Canadiens pour une meilleure santé cardiovasculaire. L'application mobile du Dr Sharma utilise l'intelligence artificielle avec rétroaction et l’assistance en temps réel pour améliorer progressivement l'activité physique. LEAP fait un don de 100 000 $ pour soutenir le développement continu de l'application du Dr Sharma dans le cadre de la campagne Souder les cœurs brisés de la Fondation du CUSM.
... See MoreSee Less

View on Facebook

Ce « Mardi je donne » est presque terminé! ⏰ Pour chaque femme dont la vie a été anéantie par le cancer de l’ovaire ou de l’endomètre. Pour chaque mère qui ne verra pas ses enfants grandir en raison de ces maladies. Pour chaque femme qui lutte actuellement pour sa vie, unissons-nous comme jamais auparavant. ❤️ The DOVEE Project

✨ Faites un don: bit.ly/3pIj2vZ

#MardiJeDonne #OsezRêverFCUSM

Giving Tuesday is nearing its end!⏱ For every woman whose life has been cut short because of ovarian or endometrial cancers. For every mother who won’t see her children grow up because of these diseases. For every woman fighting for her life right now, let’s come together like never before.

✨Donate: bit.ly/38Vtb2o

#GivingTuesday #DreamBigMUHCF
... See MoreSee Less

View on Facebook

Let’s do this, Montreal—we’re more than halfway through Giving Tuesday and we need every one of you to help us reach our $70,000 goal. 🙌 Support Dr. Gilbert, Joanne, Lawrie and the entire The DOVEE Project's Giving Tuesday dream of stopping ovarian and endometrial cancers. Combined, more than 3,000 Canadian women die each year from these cancers—but it doesn’t have to be this way. Let’s stop these deadly killers, once and for all.

✨ Donate now: bit.ly/3nREEEz

Plus de 3 000 Canadiennes succombent chaque année à ces deux cancers, mais nous pouvons les sauver. Arrêtons ces tueurs silencieux, une fois pour toutes.

✨Faites un don: bit.ly/2ISbhCC

#GivingTuesday #DreamBigMUHCF
... See MoreSee Less

View on Facebook

À l’occasion de « Mardi je donne », votre contribution sera égalée jusqu’à concurrence de 50 000 $ grâce à la générosité d’un grand donateur anonyme! La Dre Gilbert et ses collègues Centre universitaire de santé McGill - McGill University Health Centre ont mis au point un test sécuritaire et moins invasif qui permet de dépister les cancers de l’ovaire et de l’endomètre de façon plus précoce que jamais auparavant.

✨ Faites un don: bit.ly/38UHcgN
---
It's Giving Tuesday, and your donation today will be doubled up to $50,000 thanks to a generous anonymous donor. Dr. Gilbert and her colleagues @ The DOVEE Project have developed a test that offers a safe, less invasive way to detect ovarian and endometrial cancers earlier than ever before. The answer for moving this test into clinical implementation? Generous Giving Tuesday supporters like you. ❤️

✨ Donate now: bit.ly/2UEAgvY

#GivingTuesday #DreamBigMUHCF
... See MoreSee Less

View on Facebook

Demain, c’est la journée « Mardi je donne ». Voici un message important de Lawrie Shahbazian, une coordonnatrice du projet DOvEEgene The DOVEE Project

« Les femmes qui reçoivent un diagnostic de cancer de l’ovaire ou de l’endomètre se posent souvent cette question : ‘ J’ai pris soin de ma santé. J’ai passé les examens, les tests Pap et les mammographies. Qu’est-ce que j’aurais pu faire de plus?’ La réponse, c’est DOvEEgene. Notre test minimalement invasif fonctionne, ici et maintenant. Nous en sommes à la dernière étape de notre marathon, le passage aux essais cliniques de stade trois. En tant que jeune femme, je compte bien voir les résultats et les bienfaits de notre travail acharné de mon vivant. Avec votre aide, nous sauverons des vies.”

✨Faites un don: bit.ly/3l1xQ53
... See MoreSee Less

View on Facebook